Skip to main content
Interoperability

HL7 v2 vs. FHIR: Which Interoperability Standard Should Your Practice Adopt?

We compare HL7 v2 and FHIR for real-world health IT: adoption, modern APIs, security, and U.S. regulatory fit. See which one wins for your practice.

When you're standing in the middle of a clinical data integration project, the question that keeps you up at night isn't abstract—it's: Should we build our next interface on HL7 v2 or FHIR? We've all been there: the legacy system that only speaks v2, the new app that demands a RESTful API, and a pile of regulatory requirements that seem to pull in both directions. This is the fork in the road that every health informatics team faces, and the wrong turn can cost you months and millions. In this head-to-head, we'll put HL7 v2 and FHIR side by side on the criteria that actually matter when you're wiring systems together: maturity and adoption, developer experience, security and regulatory fit, and future-proofing. We'll tell you who each one is for, and then we'll make a call.

Maturity and Adoption: The Old Workhorse vs. The New Standard

If you're connecting to a hospital's legacy lab system, you'll likely be speaking HL7 v2. It's been around since 1987 and is still used by more than 95% of US healthcare organizations (HL7 International). That's not a typo—it's the lingua franca of healthcare messaging. Meanwhile, FHIR, first released in 2014, is the new kid on the block, but it's not a toy: FHIR R4, published in December 2018, was the first release with normative content, meaning it's stable enough for production use (HL7 FHIR Version History). The reality is that v2 is everywhere, but FHIR is where the industry is heading. If you need to talk to a legacy system today, v2 is your safe bet. But if you're building a new app or integrating with a modern platform, FHIR is increasingly the default.

Developer Experience: Messaging vs. RESTful APIs

Here's where the two standards diverge dramatically. HL7 v2 is a messaging standard: you send a structured message (like an ADT admit) from point A to point B, and the receiving system parses it. It's reliable, but it's not exactly developer-friendly—you often need specialized libraries and a deep understanding of the message structures. FHIR, on the other hand, is built on RESTful APIs, exchanging resources like Patient, Encounter, and Observation in JSON or XML (HL7 International). That means any web developer who knows HTTP can get started quickly. In our experience, the learning curve for FHIR is much gentler. The trade-off is that v2 has a richer set of message types for complex workflows, but FHIR's resource model is more flexible and extensible. For a typical integration project, we'd pick FHIR for its developer experience—but only if the systems you're connecting can support it.

Security and Regulatory Fit: HIPAA and Beyond

Security is non-negotiable, and both standards have to play in the same sandbox. The HIPAA Security Rule requires administrative, physical, and technical safeguards for electronic protected health information (ePHI) (45 CFR 164.308, 164.310, 164.312). That applies regardless of whether you're using v2 or FHIR. But there are differences in how they handle security. FHIR's RESTful nature makes it easier to implement OAuth2 and other modern authentication—something that's harder with v2's point-to-point messaging. On the regulatory front, the U.S. government has thrown its weight behind FHIR: the US Core Implementation Guide, based on FHIR R4, defines the minimum data elements for patient access (US Core Implementation Guide). And TEFCA, the nationwide framework for health information sharing, is designed around FHIR APIs (ONC / HHS TEFCA). If you want to stay aligned with federal interoperability initiatives, FHIR is the way to go. But don't count v2 out—it's still a workhorse for backend integrations, and it's not going away anytime soon.

Future-Proofing: Which Standard Will Still Matter in 2030?

We all know the pain of building on a technology that becomes obsolete. HL7 v2 has been around for almost 40 years, and it's not going to vanish overnight—but it's also not evolving much. The latest v2 update was published in 2011 (HL7 V2 Product Brief). FHIR, by contrast, is actively developed: R5 was published in March 2023, with 157 resources defined (HL7 FHIR Resource Index). The U.S. government is pushing FHIR through information blocking rules and TEFCA, and Medicare's MIPS Promoting Interoperability category rewards the use of certified EHR technology that supports FHIR (Federal Register CY 2026 Physician Fee Schedule). If you're making a long-term bet, FHIR is clearly the future. But that doesn't mean you should rip out your v2 infrastructure tomorrow—pragmatism matters.

Head-to-Head Comparison

Criterion HL7 v2 FHIR
Adoption Used by >95% of US healthcare orgs (HL7 International) Growing rapidly; US Core for patient access (US Core IG)
Developer Experience Messaging-based, specialized skills needed RESTful APIs, JSON/XML, easier for web devs (HL7 International)
Security Works, but limited to point-to-point Modern auth (OAuth2) easier; still HIPAA-compliant
Future-proofing Stable but stagnant; last update 2011 (HL7 V2 Product Brief) Active development; R5 (2023) with 157 resources (HL7 FHIR Resource Index)

Who Should Choose Which?

If you're a small practice that needs to exchange lab orders with a reference lab that only speaks v2, you have no choice—use v2. If you're a health IT developer building a patient-facing app that needs to pull data from multiple EHRs, FHIR is your best friend. In our opinion, the smart move is to adopt FHIR for new interfaces and APIs, while maintaining v2 for legacy connections that still work. That's the pragmatic path: don't rip and replace; build a bridge. The one thing we'd caution against is ignoring FHIR. The government is pushing it, the market is moving toward it, and if you're not at least planning for it, you'll be stuck.

Bottom Line

For any new interoperability project, we recommend starting with FHIR—it's the modern, developer-friendly, and government-endorsed choice. But keep your v2 interfaces running for legacy systems. The best move is a hybrid approach: use FHIR for new integrations and gradually migrate away from v2 over time. That way, you're not betting the farm on a technology that's on its way out, but you're also not breaking things that work.

Sources

  • HL7 International - https://www.hl7.org/fhir/
  • HL7 FHIR (Version History) - https://www.hl7.org/fhir/history.html
  • HL7 FHIR (Resource Index) - https://www.hl7.org/fhir/resourcelist.html
  • US Core Implementation Guide - https://hl7.org/fhir/us/core/
  • HL7 V2 Product Brief - https://www.hl7.org/implement/standards/product_brief.cfm?product_id=185
  • ONC / HHS (TEFCA) - https://www.healthit.gov/topic/interoperability/policy/trusted-exchange-framework-and-common-agreement-tefca
  • eCFR 45 CFR Part 164 Subpart C (Security Rule) - https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-C
  • Federal Register (CY 2026 Physician Fee Schedule) - https://www.federalregister.gov/documents/2025/11/05/2025-19787

Share this article:

Comments (0)

No comments yet. Be the first to comment!